Yes, and the DMC/DSMB will conduct the interim analysis, not the company, AS FDA GUIDELINES SUGGEST AND COMPANY HAS COMMUNICATED AND AS I HAVE SHOWN BY PROVIDING ACTUAL SOURCES AND EXAMPLES.
Last post from me on this topic. Not going to waste my time with people who don't bother reading FDA guidelines and other documents.